Tuesday, July 29, 2025
Read the Digital Magazines Subscribe to the Magazines
Subscribe

Life Sciences

DevelopmentLife SciencesMassachusettsNortheastOffice

Davis, BDG to Develop 450,000 SF Life Sciences Campus in Metro Boston

by Kristin Harlow

WATERTOWN, MASS. — A joint venture between two locally based firms, The Davis Cos. and Boston Development Group, will develop a 450,000-square-foot life sciences campus at 66 Galen St. in the western Boston suburb of Watertown. Phase I of the project, construction of which is set to begin in May, will consist of a 224,106-square-foot research and lab building. Amenities will include a fitness center, bike room and an onsite café and retail space. Elkus Manfredi is the architect for the project. About 40 percent of the site’s total acreage will be dedicated to parks and green spaces.

Continue Reading
FacebookTwitterLinkedinEmail
Hillsboro Center
FloridaLeasing ActivityLife SciencesOfficeSoutheast

JLL Arranges 25,000 SF Lease Expansion, Relocation in South Florida for Life Sciences Firm

by Julia Sanders

DEERFIELD BEACH, FLA. — JLL has arranged a 25,000-square-foot lease expansion and relocation in South Florida on behalf of DNA Labs International, a private forensic DNA lab. The lab company’s new corporate headquarters will take up the entirety of Building 3 at Hillsboro Center located at 700 W. Hillsboro Blvd. in Deerfield Beach. Ryan Nunes of JLL represented DNA Labs in the office expansion. Joe Freitas and John Criddle of Cushman & Wakefield represented the Boca Raton, Fla.-based landlord, Grover Corlew, in the lease negotiations. DNA Labs International was founded in 2004 in Deerfield Beach and is a family-run business, specializing in forensic DNA analysis for law enforcement agencies, government forensic labs and attorneys involved in the criminal law practice. Hillsboro Center includes more than 216,000 square feet of space and offers immediate access to Interstate 95. The building features an onsite cafe and restaurant options, banks, hotels and other amenities in the surrounding area.

Continue Reading
FacebookTwitterLinkedinEmail
Cambridge-Crossing
HealthcareLeasing ActivityLife SciencesMassachusettsNortheastOffice

Bristol Myers Squibb Signs 113,000 SF Life Sciences Lease Expansion in Boston

by Taylor Williams

BOSTON — Bristol Myers Squibb has signed a 113,000-square-foot life sciences lease expansion at 250 Water St. at Cambridge Crossing, a 43-acre mixed-use project at the intersection of Cambridge, Somerville and Boston. The global pharmaceutical company is adding the remaining available space to its initial lease, which was announced in August of last year. Developer DivcoWest recently topped off the 480,000-square-foot building and expects to deliver it in 2022.

Continue Reading
FacebookTwitterLinkedinEmail
Fenway-Center-Boston
DevelopmentHealthcareLife SciencesMassachusettsNortheastOfficeTop Stories

IQHQ Begins Construction on $1B Fenway Center Life Sciences Project in Boston

by Taylor Williams

BOSTON — IQHQ Inc., a developer of life sciences real estate with offices in Boston and San Diego, has begun construction on Fenway Center, a $1 billion project in Boston. IQHQ is co-developing the project with locally based firm Meredith Management. The initial phase of construction centers on the development of a 90,000-square-foot air rights deck that overlooks the Massachusetts Turnpike between Beacon Street and Brookline Avenue. The construction of the air rights deck will be the largest air rights structure built in Boston since Copley Place in 1980 and will take approximately 24 months to complete. Upon completion, Fenway Center will consist of more than 960,000 square feet of life sciences space with 10,000 square feet of retail space across two towers. Construction of the life sciences buildings is expected to be complete in early 2025. The campus will also feature 1.6 acres of landscaped green space and a parking garage that will be accessible from both buildings. The green space will include a large plaza and a public pedestrian walkway. The site is adjacent to BOWER, a new 312-unit luxury apartment complex that contains 38,000 square feet of amenity-oriented retail, the Lansdowne MBTA Commuter Rail Station, Fenway Park …

Continue Reading
FacebookTwitterLinkedinEmail
2445-Technology-Forest-Blvd.-The-Woodlands
HealthcareLeasing ActivityLife SciencesOfficeTexas

NAI Partners Negotiates 25,288 SF Life Sciences Lease in Metro Houston

by Taylor Williams

THE WOODLANDS, TEXAS — NAI Partners has negotiated a 25,288-square-foot life sciences lease for biotechnology firm Lexicon Pharmaceuticals at 2445 Technology Forest Blvd. in The Woodlands, about 30 miles north of Houston. Dan Boyles and Jon Silberman of NAI Partners represented the tenant in the lease negotiations. The duo also recently arranged the sale of Lexicon Pharmaceuticals’ former headquarters building in The Woodlands.

Continue Reading
FacebookTwitterLinkedinEmail
Leasing ActivityLife SciencesNortheastOfficePennsylvania

CBRE Negotiates 44,000 SF Life Sciences Headquarters Lease in Philadelphia

by Taylor Williams

PHILADELPHIA — CBRE has negotiated a 44,000-square-foot life sciences headquarters lease for biotechnology firm Biomeme at 401 N. Broad St. in Philadelphia. The new headquarters includes space for lab, office and manufacturing uses. Christian Dyer of CBRE represented the landlord, Netrality Data Centers, in the lease negotiations. The representative of the tenant was not disclosed. Since acquiring the 11-story building in 2014, Netrality Data Centers has invested for more than $50 million in capital improvements.

Continue Reading
FacebookTwitterLinkedinEmail
CaliforniaCivicDevelopmentLife SciencesOfficeTop StoriesWestern

BioMed Realty Wins Municipal Approval for 910,000 SF Expansion of Life Sciences Campus in Bay Area

by John Nelson

EMERYVILLE, CALIF. — The City of Emeryville in Northern California’s Bay Area has approved BioMed Realty’s proposal to expand its Emeryville Center of Innovation life sciences campus. The 12-acre property is located about four miles north of Oakland and 10 miles east of San Francisco. The expansion will add 910,000 square feet of Class A laboratory and office space to the development. Phase I of the expansion, which BioMed Realty expects to begin in 2022, will span 265,000 square feet. “We are grateful for our partnership with the City of Emeryville to develop purpose-built lab research facilities that support the growth of the industry and help our business partners attract and retain talent,” says Salil Payappilly, vice president of BioMed Realty. BioMed Realty is currently modernizing an existing 303,000-square-foot building at Emeryville Center of Innovation. The building, which is not part of the newly announced expansion, will be fully occupied by Zymergen Inc., a biomanufacturing company and Emeryville’s largest employer. Zymergen signed a lease in 2019 for its new corporate headquarters and to accommodate the expansion of its operations. BioMed Realty expects to complete Zymergen’s building in early 2023. Emeryville Mayor Dianne Martinez says that the origin of the life …

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentGeorgiaLife SciencesMixed-UseSoutheast

Trammell Crow, High Street Residential to Develop Mixed-Use Life Sciences Project Near Georgia Tech in Atlanta

by Julia Sanders

ATLANTA — Trammell Crow Co. and High Street Residential are co-developing the remaining phases of Technology Enterprise Park (TEP) in Midtown Atlanta. Georgia Advanced Technology Ventures (GATV), a Georgia Tech-led cooperative organization that is overseeing this project, chose the two firms to deliver a mixed-use, life sciences center within TEP. Construction is slated to begin in early 2022. For each of the five planned project phases of TEP, there is a grant to establish a sustainable education and training program for residents, Georgia Tech students and teachers in surrounding neighborhoods to expose them to careers in the biomedical and life sciences industries. TEP currently has two existing buildings that house research and lab space. The property will begin the park’s long-term expansion with Phase I, which will feature two buildings that include 370,000 square feet of lab and office space and 280 residential apartments.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentHealthcareLife SciencesNortheastOfficePennsylvania

PIDC, Ensemble, Mosaic to Build 220,000 SF Life Sciences Project at Philadelphia Navy Yard

by Taylor Williams

PHILADELPHIA — PIDC, in partnership with Ensemble Real Estate Investments and Mosaic Development Partners, will build a 220,000-square-foot life sciences project at the Philadelphia Navy Yard. The two-building project is part of the $400 million Phase I of a $2.5 billion expansion at the 7.5 million-square-foot mixed-use development. The building at 1201 Normandy Place will span 100,000 square feet of lab, office and research and development space. The building at 33 Rouse Blvd. will total 120,000 square feet and will house similar uses, along with manufacturing and warehousing space. Both buildings are slated for completion by the end of 2022. PIDC is the public-private partnership behind and master developer of the Philadelphia Navy Yard.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentHealthcareLife SciencesNortheastOfficePennsylvania

Brandywine, PABC to Develop 50,000 SF Life Sciences Project in Philadelphia

by Taylor Williams

PHILADELPHIA — A partnership between locally based REIT Brandywine Realty Trust (NYSE: BDN) and the Pennsylvania Biotechnology Center (PABC) will develop a 50,000-square-foot life sciences project in Philadelphia. The property will be located adjacent to Brandywine’s Schuylkill Yards mixed-use development in the University City area. Construction is scheduled to begin immediately and to be complete in the fourth quarter.

Continue Reading
FacebookTwitterLinkedinEmail
Newer Posts
Older Posts